Most first reports are incomplete. ICH E2D(R1) asks companies to seek more information, and to do it well:
- Prioritise. Highest priority: cases that are serious and unexpected. Slightly lower: serious expected and non-serious unexpected cases. Cases of special interest, such as events under enhanced monitoring at a regulator's request, are prioritised too.
- Ask specific questions, preferably with a targeted questionnaire, and where possible ask the health professionals directly involved in the patient's care.
- Document every request and attempt. For US 15-day Alert reports, when the information cannot be obtained, the company keeps records of the steps it took to seek it (21 CFR 314.80).
- Special situations. Overdose, abuse, misuse, medication errors and occupational exposure are followed up for the drugs involved and the context. Pregnancy exposures are followed up for the outcome of the pregnancy and the health of the newborn.
- Privacy. Be careful following up a message marked as private on a digital platform the company does not run: it may breach consent under local privacy rules.
Good questions serve the causality assessment: the time course, other possible causes, tests with results and normal ranges, what happened when the drug was stopped, and the outcome now. "Should she stop the drug?" is not a follow-up question: treatment is a matter for the patient's doctor.